The information and materials provided here, whether or not provided on TBI’s Substack (TBI), on third party websites, in marketing materials, newsletters or any form of publication are provided for general information and circulation only. None of the information contained here constitutes an offer (or solicitation of an offer) to buy or sell any currency, product or financial instrument, to make any investment, or to participate in any particular trading strategy. TBI does not take into account of your personal investment objectives, specific investment goals, specific needs or financial situation and makes no representation and assumes no liability to the accuracy or completeness of the information provided here. The information and publications are not intended to be and do not constit

The information and materials provided here, whether or not provided on TBI’s Substack (TBI), on third party websites, in marketing materials, newsletters or any form of publication are provided for general information and circulation only. None of the information contained here constitutes an offer (or solicitation of an offer) to buy or sell any currency, product or financial instrument, to make any investment, or to participate in any particular trading strategy. TBI does not take into account of your personal investment objectives, specific investment goals, specific needs or financial situation and makes no representation and assumes no liability to the accuracy or completeness of the information provided here. The information and publications are not intended to be and do not constit

The information and materials provided here, whether or not provided on TBI’s Substack (TBI), on third party websites, in marketing materials, newsletters or any form of publication are provided for general information and circulation only. None of the information contained here constitutes an offer (or solicitation of an offer) to buy or sell any currency, product or financial instrument, to make any investment, or to participate in any particular trading strategy. TBI does not take into account of your personal investment objectives, specific investment goals, specific needs or financial situation and makes no representation and assumes no liability to the accuracy or completeness of the information provided here. The information and publications are not intended to be and do not constit

The information and materials provided here, whether or not provided on TBI’s Substack (TBI), on third party websites, in marketing materials, newsletters or any form of publication are provided for general information and circulation only. None of the information contained here constitutes an offer (or solicitation of an offer) to buy or sell any currency, product or financial instrument, to make any investment, or to participate in any particular trading strategy. TBI does not take into account of your personal investment objectives, specific investment goals, specific needs or financial situation and makes no representation and assumes no liability to the accuracy or completeness of the information provided here. The information and publications are not intended to be and do not constit

$Moderna, Inc.(MRNA)$ is scheduled to report its fiscal Q4 2025 and full-year results on Friday, February 13, 2026, at 8:00 a.m. ET. The company is currently in a high-stakes transition from a pandemic-focused entity to a diversified biotech platform. While recent "pre-announcements" in January have already shared some high-level figures, the official report will be the definitive signal for 2026 sentiment. Moderna’s (MRNA) Fiscal Q3 2025 earnings, reported on November 6, 2025, were a pivotal moment for the company. Despite a steep year-over-year revenue decline, the report was widely viewed as a "win" because the company demonstrated it could aggressively manage its transition into a post-pandemic business. Q3 2025 Financial Summary Moderna signi

$Coinbase Global, Inc.(COIN)$ is scheduled to report its fiscal Q4 2025 earnings on Thursday, February 12, 2026, after the market close. Coming off a year of shifting market dynamics, this report is seen as a "gut check" for the stock, which has faced significant downward pressure over the last month. Investors are increasingly looking past volatile trading fees toward the company's "everything exchange" evolution. Earnings Estimates & Expectations Wall Street has become increasingly cautious leading into this print, with the consensus EPS estimate revised downward by roughly 6% in the last 30 days. Coinbase reported its fiscal Q3 2025 results on October 30, 2025. It was a standout quarter that showcased the company's aggressive "Everything Ex

Considering the battery is the most critical component of an electric vehicle (EV), understanding its condition, technology, and management is essential for ensuring long-term satisfaction, reliability, and value in your next vehicle. The battery determines the vehicle's driving range, performance, and charging speed, and it represents a significant portion of the car's overall cost and resale value.  Here is why EV battery consideration is crucial for your next vehicle purchase: 1. It Dictates Real-World Range and Performance  Capacity Loss (Degradation): EV batteries, primarily lithium-ion, naturally degrade over time, losing maximum capacity. While modern batteries are designed to last, understanding that a 10%–15% loss might occur over several years helps manage expectat

$Amazon.com(AMZN)$ $Alphabet(GOOGL)$  $Advanced Micro Devices(AMD)$  This week isn’t just another earnings cycle, it’s a stress test of whether liquidity, labour data, and earnings momentum can keep equities climbing while macro and political risks crowd the tape. I’m positioning where that decision shows up first, not after it’s obvious. 02Feb26 ET 🇺🇸 and we’re entering one of those weeks where everything converges at once. Earnings weight, labour data, shutdown politics, tariff talk, sector rotation and global policy signals are all colliding. When catalysts stack like this, price rarely moves gently. It reprices. I’m not trading headlines.

Hi Tigers 🐯 Welcome to “What the Tigers say.” 👋 The past week was the absolute peak of the Q4 Earnings Season 📊. It was a week that separated the "Real Deal" 💪 from the "Paper Tigers." 📄 We tracked the results of 10 market movers that define our economy right now 🌍: 🤖 The AI Giants: $Microsoft(MSFT)$, $Alphabet(GOOG)$, $Meta Platforms, Inc.(META)$, $SUPER MICRO COMPUTER INC(SMCI)$ 💾 The Chip Warriors:$Advanced Micro Devices(AMD)$,$Intel(INTC)$, $Texas Instruments(TXN)$ 🏗️ The Economic Backbone:

$Qualcomm(QCOM)$ is set to report its fiscal Q1 2026 earnings on Wednesday, February 4, 2026, after the market close. The stock enters this print at a crossroads: while it remains the king of the mobile SoC (System on Chip) world, it is fighting a "show me" battle to prove its AI-driven diversification into PCs, automotive, and data centers. Here is an analysis of the upcoming report and the "AI narrative" comparison with AMD. Key Metrics to Watch (Fiscal Q1 2026) The market is bracing for a "beat-and-lower" scenario, where current results look good, but future guidance reflects headwinds in the smartphone market. Qualcomm’s Fiscal Q4 2025 earnings (reported November 5, 2025) were a masterclass in "operational excellence vs. headline noise." While

The information and materials provided here, whether or not provided on TBI’s Substack (TBI), on third party websites, in marketing materials, newsletters or any form of publication are provided for general information and circulation only. None of the information contained here constitutes an offer (or solicitation of an offer) to buy or sell any currency, product or financial instrument, to make any investment, or to participate in any particular trading strategy. TBI does not take into account of your personal investment objectives, specific investment goals, specific needs or financial situation and makes no representation and assumes no liability to the accuracy or completeness of the information provided here. The information and publications are not intended to be and do not constit

The information and materials provided here, whether or not provided on TBI’s Substack (TBI), on third party websites, in marketing materials, newsletters or any form of publication are provided for general information and circulation only. None of the information contained here constitutes an offer (or solicitation of an offer) to buy or sell any currency, product or financial instrument, to make any investment, or to participate in any particular trading strategy. TBI does not take into account of your personal investment objectives, specific investment goals, specific needs or financial situation and makes no representation and assumes no liability to the accuracy or completeness of the information provided here. The information and publications are not intended to be and do not constit

The information and materials provided here, whether or not provided on TBI’s Substack (TBI), on third party websites, in marketing materials, newsletters or any form of publication are provided for general information and circulation only. None of the information contained here constitutes an offer (or solicitation of an offer) to buy or sell any currency, product or financial instrument, to make any investment, or to participate in any particular trading strategy. TBI does not take into account of your personal investment objectives, specific investment goals, specific needs or financial situation and makes no representation and assumes no liability to the accuracy or completeness of the information provided here. The information and publications are not intended to be and do not constit

$Intuitive Surgical(ISRG)$ is scheduled to report its fiscal Q4 2025 earnings on Thursday, January 22, 2026, after the market close. Because the company released preliminary results on January 14, much of the revenue data is already known. This shifts the focus of the actual earnings call toward margins, profitability, and 2026 guidance. Q4 2025 Preliminary Numbers (Known) Revenue: ~$2.87 billion (up 19% YoY), beating the $2.73B consensus. Procedure Growth: Worldwide da Vinci/Ion procedures grew ~18%. System Placements: 532 systems placed (vs. 493 last year), including 303 da Vinci 5 (dV5) systems. Ion Growth: Ion procedures surged ~44% YoY, showing strong diversification beyond soft-tissue robotics. Intuitive Surgical (ISRG) reported its Fiscal Q

AI has entered a full-scale infrastructure build-out phase. We expect annual AI-related infrastructure spending to exceed US$400–500 billion by 2026, driven by accelerated data-centre construction, higher-density compute requirements, and rising power and cooling needs. At this level, AI infrastructure investment approaches ~2% of US GDP, placing it alongside past general-purpose technology cycles such as cloud computing and telecommunications. However, this remains a front-loaded capital cycle. Cash outflows precede revenue, and monetisation remains uneven across sectors. For current equity valuations to be sustained, the AI ecosystem must ultimately generate US$1.7–2.5 trillion in incremental annual revenue by the end of the decade. As infrastructure spending accelerates into 2026, balan

$Goldman Sachs(GS)$ is scheduled to report its fiscal Q4 2025 earnings on Thursday, January 15, 2026, before the market opens. The bank enters this report following a massive rally—shares are up roughly 65% over the last 12 months—and is trading near all-time highs (around $940–$950). This sets a high bar for performance, as much of the "dealmaking renaissance" may already be priced in. Key Consensus Estimates (Q4 2025) Earnings Per Share (EPS): ~$11.69 (Revisions have trended upward by 6% in the last 30 days). Revenue: ~$14.54 billion (Expected growth of ~4.8% YoY). Implied Move: Options markets suggest a potential stock move of +/- 4.5% to 5.5% post-earnings. Goldman Sachs reported its fiscal Q3 2025 results on October 14, 2025. The quarter was ch

As 2025 Q4 earnings season enters its most critical week in late January 2026, the US stock market stands at a crossroads of multiple narratives. This week, more than 100 S&P 500 components are scheduled to report their results.I. S&P 500 Status Quo: 10 Consecutive Quarters of Growth and Valuation ChallengesAccording to the latest FactSet data, the performance of the S&P 500 for Q4 2025 is characterized by steady growth but a declining "surprise factor":Earnings Performance: The blended earnings growth rate for the S&P 500 currently stands at 8.2%. If this holds, it will mark the 10th consecutive quarter of year-over-year earnings growth for the index.Revenue Growth: The blended revenue growth rate is 7.8%, representing the second-highest growth rate for the index since Q3

$Microsoft(MSFT)$  $Meta Platforms, Inc.(META)$  $Tesla Motors(TSLA)$  💼 Earnings concentration, volatility expansion, and dispersion risk Next week sets up as a high-dispersion, flow-led market environment where mega-cap earnings, macro catalysts, and options positioning converge. This is not a single-stock tape. It is a cross-sector liquidity event where correlations can fracture, leadership can rotate, gamma can flip intraday, and volatility becomes a strategic edge. In regimes like this, capital flow, positioning, liquidity pockets, and factor rotation matte